The Pinoy Business Chronicle

Business news and analysis. Covering financial news, economic issues, stock market data, local business, business policy and more.

National Business News

COVID-19 infections nearing 430,000

covid 19 infections nearing 430000 - COVID-19 infections nearing 430,000

The Department of Health (DoH) reported 1,631 coronavirus infections on Friday, bringing the total to 425,918.
The death toll rose by 46 to 8,255, while recoveries increased by 370 to 387,616, it said in a bulletin.

There were 30,047 active cases, 84.3% of which were mild, 8.3% did not show symptoms, 4.7% were critical, 2.5% were severe and 0.26% were moderate.

Quezon City reported the highest number of cases at 116, followed by Rizal at 101, Davao City at 95, Laguna at 89 and Manila at 65.

Ten duplicates were removed from the tally, while 25 cases reported as deaths were reclassified as active cases. Eight previous deaths were also tagged as recoveries, the agency said.

Thirteen cases reported as recoveries were reclassified as deaths. Ten laboratories failed to submit their data on Nov. 26, DoH said.

The coronavirus has sickened about 61.4 million and killed 1.4 million people worldwide, according to the Worldometers website, citing various sources including data from the World Health Organization.

About 42.4 million people have recovered, it said.

Meanwhile, the private sector under Go Negosyo, the government, and UK-based drug maker AstraZeneca signed a deal for the purchase of 2.6 million doses of vaccines the company is developing.

Half of the vaccines would be alloted to the private sector and the other half will be donated to the government, Joey A. Concepcion, presidential adviser for entrepreneurship and founder of Go Negosyo, told an online news briefing on Friday.

“Through this partnership, we’re thinking and acting ahead of the virus,” Vaccine czar Carlito Galvez, Jr. told the same briefing.

He said they are negotiating with AstraZeneca for a million more orders of the vaccines. AstraZeneca is applying for clinical trials in the country. — Vann Marlo M. Villegas

Leave a Reply

Theme by Anders Norén